Stockreport

HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target [Yahoo! Finance]

GlaxoSmithKline PLC  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF On December 10, HSBC analyst Rajesh Kumar raised the firm's price target on GSK plc (NYSE:GSK) to 1,500 GBp from 1,200 GBp and kept a Reduce rating on the shares. The m [Read more]